These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8154531

  • 1. Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis.
    Santos CI, Huang AJ, Abelson MB, Foster CS, Friedlaender M, McCulley JP.
    Am J Ophthalmol; 1994 Apr 15; 117(4):488-97. PubMed ID: 8154531
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis.
    Caldwell DR, Verin P, Hartwich-Young R, Meyer SM, Drake MM.
    Am J Ophthalmol; 1992 Jun 15; 113(6):632-7. PubMed ID: 1598953
    [Abstract] [Full Text] [Related]

  • 4. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.
    Verin P, Allewaert R, Joyaux JC, Piozzi E, Koliopoulos J, Bloch-Michel E, Lodoxamide Study Group.
    Eur J Ophthalmol; 2001 Jun 15; 11(2):120-5. PubMed ID: 11456011
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group.
    Richard C, Trinquand C, Bloch-Michel E.
    Eur J Ophthalmol; 1998 Jun 15; 8(4):207-16. PubMed ID: 9891891
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis.
    Akpek EK, Hasiripi H, Christen WG, Kalayci D.
    Ophthalmology; 2000 Feb 15; 107(2):263-9. PubMed ID: 10690822
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.
    Avunduk AM, Avunduk MC, Kapicioglu Z, Akyol N, Tavli L.
    Ophthalmology; 2000 Jul 15; 107(7):1333-7. PubMed ID: 10890862
    [Abstract] [Full Text] [Related]

  • 9. Lodoxamide in vernal keratoconjunctivitis.
    Lee S, Allard TR.
    Ann Pharmacother; 1996 May 15; 30(5):535-7. PubMed ID: 8740338
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis.
    Oguz H, Bitiren M, Aslan OS, Ozardali I.
    Acta Med Okayama; 1999 Jun 15; 53(3):123-6. PubMed ID: 10410789
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of the efficacy and safety of lodoxamide in patients with allergic eye diseases].
    Dekaris I, Gabrić N, Lazić R, Bosnar D, Cima I, Stipić A.
    Acta Med Croatica; 2002 Jun 15; 56(3):93-8. PubMed ID: 12630339
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.
    Leonardi A, Borghesan F, Avarello A, Plebani M, Secchi AG.
    Br J Ophthalmol; 1997 Jan 15; 81(1):23-6. PubMed ID: 9135403
    [Abstract] [Full Text] [Related]

  • 19. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB, Torkildsen GL, Williams JI, Gow JA, Gomes PJ, McNamara TR, Bepotastine Besilate Ophthalmic Solutions Clinical Study Group.
    Clin Ther; 2009 Sep 15; 31(9):1908-21. PubMed ID: 19843481
    [Abstract] [Full Text] [Related]

  • 20. Lodoxamide for vernal keratoconjunctivitis.
    Med Lett Drugs Ther; 1994 Mar 18; 36(918):26. PubMed ID: 8121328
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.